ENE. A. Nadezhdina

E. A. Nadezhdina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


E. A. Nadezhdina has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ethanol Sclerotherapy Combined with Radiofrequency Ablation in the Treatment of Toxic Adenoma: Clinical Case

    by G. T. Gumerova, В. А. Макарьин, A. F. Tushova, A. F. Fazlyeva, A. I. Ishbulatova, S. P. Klimets, E. A. Nadezhdina, A. D. Neryakhin

    Introduction. Thyrotoxic states are the result of an overproduction of thyroid hormones. Statistics from Russia indicate an increasing incidence of thyrotoxicosis, with 132 cases documented per 100,000 population in 2018. Diffuse toxic goiter is among the most frequent pathologies associated with thyrotoxic conditions. Hyperthyroidism can also result from toxic thyroid adenomas. Toxic nodular goiter is a condition that can manifest in various ways, including single lobe involvement with a solitary nodule or multiple nodules within one or both lobes. The clinical features of these adenomas encompass local symptoms, including cosmetic concerns, and systemic thyrotoxicosis, which inform subsequent management strategies. Aim. The development of personalized, minimally invasive approaches for treating thyroid neoplasms is driven by the need to preserve functioning organ tissue. Materials and methods. This article details a clinical case involving a patient diagnosed with nodular goiter exhibiting signs of thyrotoxicosis. We developed a combined surgical intervention, involving staged ethanol sclerotherapy followed by radiofrequency ablation of the nodule. Results and discussion. The minimally invasive thyroid intervention resulted in the normalization of hormonal balance, a 7-fold reduction in nodule size, an improvement in quality of life, and the restoration of natural neck contours. Conclusion. The study highlights the potential of interventional endocrine surgery as a means of preserving organ function in patients with toxic nodular formations.

  • Open Access

    Biopolymer crosslinking: Application and prospects

    by M. M. Bikbov, I. R. Kabirov, A. R. Khalimov, A. D. Neryakhin, P. N. Shmelkova, D. Kh. Gainullina, L. S. Gumerova, A. A. Tukhbatullin, A. A. Akhunzyanov, E. A. Nadezhdina

    Crosslinking is a method of linking together high-molecular compounds by forming new chemical cross linkages inside and between macrochains. At the same time, various agents can act as cross linkers, i.e., chemical compounds, ultraviolet radiation, etc. Crosslinking of biotissues is known for improving their mechanical strength, increasing structural density, and reducing bioscaffold permeability. This review aims to characterize possible applications of cross-linking technology in various branches of medicine, i.e., ophthalmology, traumatology, urology, gastroenterology, oncology, bioengineering, and others. A review of domestic and foreign publications was carried out using the database and resources of search systems of scientific electronic libraries such as PubMed, elibrary.ru, Google Scholar, Science Direct, and the library stock of Bashkir State Medical University for the period from 1994 to 2023. The study of available literature sources makes it possible to conclude that the method of ultraviolet crosslinking is currently widely used in ophthalmology, while various modifications of crosslinking have prospects in medicine and related industries and can become the basis for the creation of bioengineered products and original medical technologies aimed at improving the effectiveness of treatment of various human diseases.